Anti-VEGF Treatment Strategies for Wet AMD

Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovach, Jaclyn L., Schwartz, Stephen G., Flynn, Harry W., Scott, Ingrid U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317200/
https://www.ncbi.nlm.nih.gov/pubmed/22523653
http://dx.doi.org/10.1155/2012/786870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317200/
https://www.ncbi.nlm.nih.gov/pubmed/22523653
http://dx.doi.org/10.1155/2012/786870

Ejemplares similares